Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medical Devices
Safety Information
Safety communications
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
COVID-19 Updates
Our role
Safety Information
Reporting safety issues
Monitoring device safety
Safety communications
About HPRA Safety Notices
Manufacturer's Field Safety Notices
User Engagement
Consumer advice
Regulatory Information
Registration
Medical Devices News & Events
Special Topics
Contact Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Animas Insulin Pump (IR 1200, 2020, One Touch Ping, Vibe)
Notice type:
Advisory
Date:
28/08/2012
Product name or type:
Animas Insulin Pump (IR 1200, 2020, One Touch Ping, Vibe)
Reference:
SN2012(14)
Manufacturer Or Supplier:
Animas Corporation, a Johnson & Johnson Company
Target Audience:
Diabetes clinics/outpatients
Diabetes nurse specialists
Endocrinology units
Medical directors
Outpatient clinics
Paediatricians
Pharmacists
Risk managers
Supplies managers
Community nurses
General practitioners
Private medical practitioners
Practice nurses
School nurses
Clinics
Hospitals
Nursing Homes
Community Care Managers
Community Therapists
Carers
Please bring this safety notice to the attention of all who need to be aware of it.
Problem Or Issue:
There is a risk of compromised insulin delivery whereby keypad buttons become unresponsive. The issue can arise due to wear and tear of keypads on the insulin pump, or sticking of keypad buttons.
Background Information Or Related Documents:
Animas Corporation has received an increase in complaints relating to the durability of insulin pump keypads. Over time, tearing and peeling of the keypad buttons can occur. Keypad buttons can also stick and become unresponsive. An average time to failure of approximately 18 months was reported by the manufacturer.
Animas Corporation has a new keypad design which is incorporated into all pumps distributed post February 2012. Newer keypad designs are not affected by this problem. Animas Corporation has provided the attached Patient Notification to affected customers providing information.
The Irish Medicines Board (IMB) is issuing this Safety Notice to ensure all Animas Insulin Pump users are aware of the issue.
Animas Insulin Pump (IR 1200, 2020, One Touch Ping, Vibe Document
Actions To Be Taken:
1. Ensure that all pump users are aware of the information provided in the attached Field Safety Notice (FSN) issued recently by Animas.
2. Pump users experiencing problems with their device or experiencing keypad issues are encouraged to contact Animas without delay to arrange for a replacement as outlined in the FSN.
3. Pump users are encouraged to report any issues with pump keypad both to Animas and to the IMB using the contact details provided below.
Further Information:
Enquiries to the manufacturer should be addressed to:
Animas Corporation
Animas UK & Ireland
Telephone:
1800 812 715
E-mail:
AnimasUK@its.jnj.com
or via the website at:
https://www.animascorp.co.uk/contact
All adverse incidents relating to a medical device should be reported to the:
Health Products Regulatory Authority
Kevin O’Malley House
Earlsfort Centre
Earlsfort Terrace
Dublin 2
Telephone: +353-1-6764971
Fax: +353-1-6344033
E-mail:
devicesafety@hpra.ie
Website:
www.hpra.ie
Please click here to view a PDF Version of this Safety Notice
Please click her to view a copy of the Field Safety Notice
« Back
Date Printed: 20/09/2024